A big pharma company aimed to develop a rapid lateral flow assay to detect a biomarker indicating infection of a highly contagious, yet not always symptomatic, virus. They sought external service providers to develop a suitable affinity reagent and develop a diagnostic assay. Discover how Tango Biosciences’ combination of high-quality antibody libraries and custom phage display and binding assay capabilities was critical for the completion of multiple screens in weeks, advancing the program ahead of schedule.
Subscribe to our email newsletter to access this Case Study
We promise not to spam you, only share relevant updates about Tango Biosciences.
"*" indicates required fields
